William McKee
Chief Financial Officer, BARR PHARMACEUTICALS INC.
Companies
- Assertio Holdings, Inc.Board member May 21, 2020 to now1
- Rein Therapeutics, Inc.Board member Jun 24, 2019 to Jun 17, 20222
- C4 Therapeutics (United States)Chief financial officer Oct 1, 2020 to Oct 6, 20203
- AGILE THERAPEUTICS INCBoard member May 22, 2014 to Jun 7, 20194
- Dare Bioscience, Inc.Board member Apr 10, 2014 to Jan 5, 20175
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Assertio Holdings, Inc.0 shares6Jun 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 16, 2026U 27,936 shares of Assertio Holdings, Inc.6
- May 5, 2026Granted 4,851 shares of Assertio Holdings, Inc.7
- May 7, 2025Granted 53,750 shares of Assertio Holdings, Inc.8
- May 23, 2024Granted 53,750 shares of Assertio Holdings, Inc.9
- Aug 14, 2023Sold 22,000 shares at $3.14 of Assertio Holdings, Inc.10
- May 10, 2023Granted 31,194 shares of Assertio Holdings, Inc.11
- May 12, 2022Sold 22,322 shares at $2.35 of Assertio Holdings, Inc.12
- May 4, 2022Granted 86,286 shares of Assertio Holdings, Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARAGILE THERAPEUTICS INC, Board member
- 5SEC EDGARDare Bioscience, Inc., Board member
- 6
- 7SEC EDGARForm 4 filed May 6, 2026
- 8SEC EDGARForm 4 filed May 9, 2025
- 9SEC EDGARForm 4 filed May 28, 2024
- 10SEC EDGARForm 4 filed Aug 15, 2023
- 11SEC EDGARForm 4 filed May 12, 2023
- 12SEC EDGARForm 4 filed May 16, 2022
- 13SEC EDGARForm 4 filed May 6, 2022